申请人:——
公开号:US20020115663A1
公开(公告)日:2002-08-22
The present invention is directed to novel pyridazine compounds of the formula I
1
as well as pharmaceutically and pharmacologically acceptable salts, and hydrates thereof; to a process for their preparation, their use and pharmaceutical compositions comprising said novel compounds. These novel compounds are useful in therapy, particularly for the treatment of type 2 diabetes mellitus.
本发明涉及一种新型吡啶并嗪化合物,其化学式为I1,以及其药学和药理学上可接受的盐和水合物;以及它们的制备方法,用途和包含这些新型化合物的药物组合物。这些新型化合物在治疗中具有用途,特别是用于治疗2型糖尿病。